glp 1 drugs and autoimmune disease A Closer Look at the Dermatological Profile of GLP-1 Agonists GLP-1 Medications for Weight Loss:

by Frederick Cheng, R.Ph., and Christine Cheng, R.Ph

Aging (Albany NY) 13 (22), 2451124523

In a 56-day consumer study, dark spots improved by 7.7 percent, skin elasticity increased 4 percent and moisture rose 13 percent, according to Alma, which is partnering with beauty brands through a private-label model instead of selling directly to consumers

The effect of GLP-1 was studied by using a dextran sulfate sodium (DSS)-induced colitic mice and lipopolysaccharide (LPS) treated RAW264.7 cells (macrophage cell line) under in vivo and in vitro conditions, respectively

It is not FDA-approved for weight loss: its clinical development was halted after Phase 2b, so any use is off-label and should be supervised by a licensed provider